INSULIN DEGLUDEC for Device therapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where INSULIN DEGLUDEC was used for Device therapy.
Most Reported Side Effects for INSULIN DEGLUDEC
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Blood glucose increased | 2,644 | 23.0% | 7 | 278 |
| Blood glucose decreased | 983 | 8.5% | 8 | 124 |
| Hypoglycaemia | 762 | 6.6% | 21 | 357 |
| Nausea | 543 | 4.7% | 220 | 147 |
| Drug ineffective | 449 | 3.9% | 54 | 109 |
| Dyspnoea | 390 | 3.4% | 91 | 126 |
| Vomiting | 381 | 3.3% | 227 | 164 |
| Stress | 368 | 3.2% | 231 | 117 |
| Weight increased | 364 | 3.2% | 1 | 38 |
| Constipation | 334 | 2.9% | 220 | 119 |
| Off label use | 332 | 2.9% | 191 | 135 |
| Glycosylated haemoglobin increased | 326 | 2.8% | 2 | 46 |
| Abdominal distension | 313 | 2.7% | 225 | 117 |
| Fall | 304 | 2.6% | 6 | 129 |
| Condition aggravated | 298 | 2.6% | 145 | 166 |
Other Indications for INSULIN DEGLUDEC
Product used for unknown indication (4,244)
Type 2 diabetes mellitus (4,068)
Type 1 diabetes mellitus (1,459)
Diabetes mellitus (1,402)
Diabetes mellitus inadequate control (39)
Latent autoimmune diabetes in adults (37)
Blood glucose increased (20)
Diabetes mellitus management (10)
Pancreatogenous diabetes (10)
Blood glucose abnormal (9)